Results 201 to 210 of about 983,540 (218)

Correction: Omole et al. Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age. <i>Vaccines</i> 2025, <i>13</i>, 192. [PDF]

Vaccines (Basel)
Omole T, Pelayo E, Weinberg AS, Chalkias S, Endale Z, Tamms G, Sterling TM, Good L, Shekar T, Johnson M, Banniettis N, Buchwald UK, Esteves-Jaramillo A.   +12 more
europepmc   +1 more source

Eosinophilic Granulomatosis with Polyangiitis after mRNA-1273 SARS-CoV-2 Vaccine

, 2023
Mencarelli L, Ribi C, Moi L, Dewarrat N, Monti M, Alberio L, Ringwald M, Swierdzewska K, Panagiotis A.   +8 more
europepmc   +1 more source

Vaccination with mRNA-1273 prior to SARS-CoV-2 challenge provides viral control and spurs eosinophil infiltration.

Kathryn M. Moore (4815210), Stephanie L. Foster (22766445), Meenakshi Kar (3178761), Katharine A. Floyd (22766448), Elizabeth J. Elrod (22766451), M. Elliott Williams (21499905), Jacob Vander Velden (22766454), Madison Ellis (22766457), Ansa Malik (22766460), Bushra Wali (713582), Stacey Lapp (1867213), Amanda Metz (2899019), Steven E. Bosinger (8777792), Vineet D. Menachery (10048362), Robert A. Seder (11663411), Rama Rao Amara (8318937), Jacob E. Kohlmeier (17661183), Arash Grakoui (53612), Mehul S. Suthar (11349011)   +18 more
openalex   +1 more source

BNT162b2 Versus mRNA-1273 Vaccines: Comparative Analysis of Long-Term Protection Against SARS-CoV-2 Infection and Severe COVID-19 in Qatar. [PDF]

Influenza Other Respir Viruses
Chemaitelly H, Ayoub HH, Coyle P, Tang P, Hasan MR, Yassine HM, Al Thani AA, Al-Kanaani Z, Al-Kuwari E, Jeremijenko A, Kaleeckal AH, Latif AN, Shaik RM, Abdul-Rahim HF, Nasrallah GK, Al-Kuwari MG, Butt AA, Al-Romaihi HE, Al-Thani MH, Al-Khal A, Bertollini R, Abu-Raddad LJ.   +21 more
europepmc   +1 more source

Multimodal profiling of biostabilized human skin modules reveals a coordinated ecosystem response to injected mRNA-1273 COVID-19 vaccine. [PDF]

Allergy
Scholaert M, Peries M, Braun E, Martin J, Serhan N, Loste A, Bruner A, Basso L, Chaput B, Merle E, Descargues P, Pagès E, Gaudenzio N.   +12 more
europepmc   +1 more source

Adverse events following immunization of mRNA-1273 (Moderna) booster vaccine in clerkship students

Hari Hendarto, Femmy Nurul Akbar, Narila Mutia Nasir, Endah Wulandari, Hadianti Adlani   +4 more
openalex   +2 more sources

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study. [PDF]

EClinicalMedicine
Garrett N, Tapley A, Hudson A, Dadabhai S, Zhang B, Mgodi NM, Andriesen J, Takalani A, Fisher LH, Kee JJ, Magaret CA, Villaran M, Hural J, Andersen-Nissen E, Ferarri G, Miner MD, Le Roux B, Wilkinson E, Lessells R, de Oliveira T, Odhiambo J, Shah P, Polakowski L, Yacovone M, Samandari T, Chirenje Z, Elyanu PJ, Makhema J, Kamuti E, Nuwagaba-Biribonwoha H, Badal-Faesen S, Brumskine W, Coetzer S, Dawson R, Delany-Moretlwe S, Diacon AH, Fry S, Gill KM, Ebrahim Hoosain ZA, Hosseinipour MC, Inambao M, Innes C, Innes S, Kalonji D, Kasaro M, Kassim P, Kayange N, Kilembe W, Laher F, Malahleha M, Maluleke VL, Mboya G, McHarry K, Mitha E, Mngadi K, Mda P, Moloantoa T, Mutuluuza CK, Naicker N, Naicker V, Nana A, Nanvubya A, Nchabeleng M, Otieno W, Potgieter EL, Potloane D, Punt Z, Said J, Singh Y, Tayob MS, Vahed Y, Wabwire DO, McElrath MJ, Kublin JG, Bekker LG, Gilbert PB, Corey L, Gray GE, Huang Y, Kotze P, CoVPN 3008 Ubuntu Study Team.   +80 more
europepmc   +1 more source